Nutritional modulation of male fertility: a molecular-focused scoping review Authors: Shalaka Ramgir-Naidu, Yusuf Abdulmalik Abubakar, Meghavi Soni Published: 2026 ABSTRACT AbstractBackgroundNutrition has a profound impact on male reproductive well-being through its influence on molecular mechanisms involved in spermatogenesis, sperm function, and endocrine regulation. Elucidation of these nutrition–fertility relationships at the molecular level may inform future research directions, although clinical application remains uncertain. The review critically assesses how nutritional interventions regulate gene expression, protein synthesis, and cellular signaling pathways controlling sperm concentration, motility, morphology, and DNA integrity.Main bodyThis review discusses molecular mechanisms connecting nutritional components to male fertility results. Micronutrients such as vitamins C, D, E, zinc, selenium, and folate have been implicated in oxidative stress regulation through molecular processes, primarily based on preclinical and observational evidence. Zinc has been primarily shown in experimental and observational studies to act as a cofactor in enzymes of testosterone biosynthesis, preserve sperm membrane phospholipid integrity through metallothionein binding, and modulate flagellar dynein ATPase activity; however, randomized controlled evidence remains limited. In mechanistic and animal studies, Omega-3 fatty acids, particularly DHA, are incorporated into sperm membrane phospholipids in mechanistic and animal models, increasing membrane fluidity and influencing mitochondrial respiratory chain efficiency through cardiolipin modification; while human interventional findings remain heterogeneous. Mechanistic data indicate that Vitamin C quenches hydroxyl radicals as an electron donor, whereas coenzyme Q10 facilitates efficient mitochondrial electron transport, together inhibiting oxidative damage to sperm DNA; although clinical benefits are not consistently demonstrated. However, diets high in processed foods and saturated fats have been associated with increased lipid peroxidation and inflammatory signalling, which may adversely influence spermatogenesis, potentially involving epigenetic regulation.MethodsA scoping narrative literature review was conducted using PubMed, Scopus, and Web of Science (January 2000–March 2025). Human, animal, and in vitro studies examining nutritional exposures, molecular mechanisms, and semen parameters were included.ConclusionThis review synthesizes molecular evidence linking nutrition to male fertility through defined biochemical and cellular pathways. By critically evaluating supportive, null, and context-dependent findings, it highlights where mechanistic data align with clinical observations and where translation remains limited. This study identifies key gaps in long-term adaptation, nutrient–gene interactions, and dose–response relationships, underscoring the need for well-designed clinical trials incorporating validated molecular biomarkers. The existing literature is predominantly derived from preclinical and observational studies, with limited high-quality randomized controlled trials. Future research integrating nutrigenomics and epigenetic mechanisms will be essential to determine whether targeted nutritional strategies can be reliably applied in male reproductive health before routine clinical implementation can be recommended.Keywords: Nutrition, Male infertility, Oxidative stress, Molecular mechanism Introduction Male infertility is a complex condition affecting approximately 7–10% of men globally and contributes to nearly half of all cases of couple infertility [1]. Nutrition is increasingly recognized as a key modifiable factor influencing reproductive health. By affecting sperm production, motility, and hormonal balance, dietary intake can impact fertility outcomes. Certain nutrients, including omega-3 fatty acids, folate, zinc, and vitamins C, D, and E, have been associated with improved sperm parameters and reduced oxidative stress, although results vary across study designs [2]. Conversely, diets high in saturated fats, processed foods, and refined sugars may negatively affect hormone levels and sperm DNA integrity, potentially mediated by increased inflammation and oxidative stress [3, 4]. Addressing nutritional inadequacies has therefore been proposed as a supportive strategy to maintain male reproductive health, although definitive clinical evidence remains limited. The current evidence base is disproportionately composed of mechanistic and observational studies, whereas adequately powered randomized controlled trials remain comparatively scarce and methodologically heterogeneous. The available literature encompasses distinct but frequently conflated constructs, including whole dietary patterns, correction of clinically relevant nutrient deficiencies, and supraphysiological supplementation. Evidence derived from dietary pattern analyses reflects complex nutrient interactions and broader lifestyle correlates, whereas supplementation trials evaluate isolated exposures under controlled conditions. These study designs are not directly interchangeable, and findings from one framework cannot be assumed to generalize to another. Mixed or null results observed in several controlled antioxidant trials further illustrate the limitations of extrapolating mechanistic plausibility to consistent clinical efficacy. Nutrients influence male fertility through multiple cellular and molecular pathways. Antioxidants such as vitamins C and E, selenium, and polyphenols protect sperm from Reactive Oxygen Species (ROS), limiting lipid peroxidation, mitochondrial dysfunction, and DNA damage [5, 6]. Fatty acids, particularly docosahexaenoic acid and other omega-3 polyunsaturated fatty acids (PUFAs), are incorporated into sperm phospholipid membranes, enhancing fluidity and mitochondrial efficiency, which supports ATP production required for motility [7]. Folate and vitamin B12 contribute to one-carbon metabolism and DNA methylation, preserving genomic stability during spermatogenesis [8]. Amino acids, including L-arginine, taurine, and L-carnitine, regulate mitochondrial bioenergetics, nitric oxide signalling, and chromatin stabilization [9]. Collectively, these molecular mechanisms establish biological plausibility linking nutrition, redox balance, and sperm function; however, biological plausibility does not in itself establish clinical efficacy. There are still important research gaps. Long-term studies examining the effects of dietary modifications on reproductive outcomes are scarce [10, 11]. The interactions between specific nutrients and genetic or epigenetic factors remain unclear. Most evidence comes from small observational studies, with limited representation of diverse populations [2]. Few randomized controlled trials have rigorously assessed the relationship between male fertility and diet [2, 12, 13]. Additionally, heterogeneity in baseline nutritional status, dosing strategies, study duration, and reproductive endpoints limits cross-study comparability and reproducibility. These limitations highlight the need for a comprehensive review that synthesizes current evidence, evaluates methodological quality, and identifies nutrients or dietary patterns that could support male reproductive health. The purpose of this review is to examine specific nutrients and their classifications’ influence on male fertility markers, including overall spermatogenic potential. By synthesizing evidence from observational studies, interventional trials, and mechanistic investigations, this review critically evaluates both supportive and conflicting findings, including studies reporting positive molecular effects, null associations, or context-dependent outcomes. Rather than assuming uniform benefit, it reviews molecular evidence on oxidative stress, mitochondrial function, and hormonal pathways to clarify which findings are supported, uncertain, or not reflected in clinical outcomes. By doing so, this review provides clinicians and researchers with a balanced framework to interpret existing evidence, recognize methodological limitations, and prioritize biologically plausible targets and validated biomarkers for hypothesis-driven investigation in male reproductive research. Methods This scoping review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) guidelines. A total of 983 records were identified. After removing duplicates and ineligible records, 84 studies were included in the final synthesis. The objective was to map current evidence on how nutritional status and targeted interventions influence oxidative stress pathways, molecular signalling mechanisms, and sperm quality in infertile men. Review questions What aspects of nutritional status have been investigated in relation to male infertility? What aspects of nutritional status have been investigated in relation to male infertility? How does altered nutritional status influence oxidative stress and redox balance in the male reproductive system? How does altered nutritional status influence oxidative stress and redox balance in the male reproductive system? What molecular pathways and cellular mechanisms link nutrition-related factors to impaired spermatogenesis and sperm function? What molecular pathways and cellular mechanisms link nutrition-related factors to impaired spermatogenesis and sperm function? Eligibility criteria A systematic search was conducted across PubMed, Scopus, and Web of Science using a combination of free-text terms and Boolean operators to target male infertility, nutrition, oxidative stress, and molecular mechanisms. The search strategy combined free-text terms and Boolean operators as follows: TITLE-ABS-KEY ((“male infertile*” OR “male subfertil*” OR “ male sterility*” OR “infertile male*” OR “sperm quality” OR “ sperm dysfunction” OR spermatogenesis) AND (nutrition OR diet* OR nutrient* OR “dietary pattern*” OR antioxidant* OR vitamin* OR mineral*) AND (“oxidative stress” OR “reactive oxygen species” OR ROS OR redox OR oxidant*) AND (“molecular mechanis*” OR pathway* OR signal* OR gene* OR epigenetic* OR proteomic* OR metabolomic*) AND (human* OR men OR patient* OR clinical*) AND (rat OR rats OR mouse OR mice OR murine OR animal* OR bovine OR porcine OR ovine)). The search returned 983 records. Predefined eligibility criteria ensured conceptual and methodological comparability. We included peer-reviewed. Of these, 184 were accessible and assessed against the inclusion criteria; ultimately, 84 studies met all criteria and were included in the synthesis. This delineates studies concerning human males diagnosed with infertility or subfertility. The intervention or exposure encompasses nutritional status, dietary patterns, and mechanistic and preclinical investigations were incorporated to substantiate biological plausibility through molecular pathways. Comparators faced no limitations, thereby accommodating studies either with or without a control group. The principal outcomes included sperm parameters, oxidative stress indicators, molecular biomarkers, and mechanistic processes. Eligible study types are original peer-reviewed publications from 2014 to 2024, covering clinical, observational, and preclinical reviews, meta-analyses, and narrative papers, animal studies, in vitro studies lacking fertility-related outcome or molecular/oxidative stress endpoint and studies not directly linking nutrition to fertility, conference abstracts, editorials, and commentaries, not linked to clinical or mechanistic outcomes in human sperm, were excluded. This review synthesises current evidence on how nutritional exposure may influence male reproductive function via molecular pathways related to oxidative balance, mitochondrial activity, endocrine signalling, and sperm genomic integrity. While numerous nutrients and dietary patterns are associated with favourable reproductive parameters, much of the supporting evidence remains observational or mechanistic, with limited confirmation from well-powered randomised trials using fertility-relevant clinical endpoints. Overall, the findings indicate that adequate dietary patterns are biologically relevant to male reproductive health, but routine targeted supplementation or therapeutic nutritional modulation cannot yet be considered evidence-based clinical practice. Study selection Records were imported into reference management software, where duplicates were systematically removed to streamline the process. Two independent reviewers then screened titles and abstracts against predefined eligibility criteria, ensuring rigorous initial filtering. Full texts of potentially relevant studies were assessed for inclusion. Any disagreements between reviewers were resolved through discussion or, when needed, consultation with a third reviewer, minimising bias and enhancing reliability. Screening was performed by a single reviewer, with the algorithm prioritising abstracts based on predicted relevance, while the reviewer made all inclusion and exclusion decisions in accordance with predefined eligibility criteria. This hybrid workflow increased screening efficiency, transparency, and reproducibility. Screening stopped once 520 consecutive abstracts were classified as irrelevant, by which point 757 records had been screened, and 184 studies met criteria for full-text assessment. In addition, manual title and abstract screening was conducted to validate the machine-assisted process, which identified two additional potentially relevant articles, yielding 84 full texts for detailed review. While no formal quality appraisal tool was used, study quality was assessed through clearly defined and rigorously applied eligibility criteria, standardised outcome measures, and transparent documentation of study design and analytical approaches. This approach aligns with evidence-mapping and knowledge gap map methodologies that prioritise transparency and comparability of evidence. Review procedures were defined a priori and are reported transparently in accordance with the PRISMA-ScR guidelines, as shown in Fig. 1. PRISMA flow diagram of study selection Data extraction and synthesis Data were extracted using a standardized form capturing study design, population characteristics, type of nutritional exposure (dietary pattern, nutrient status, or supplementation), and key reproductive outcomes, including semen parameters, oxidative stress markers, hormonal measures, and molecular endpoints. The study model (clinical, observational, animal, or in vitro) was recorded to contextualize evidentiary weight. Due to heterogeneity in design and outcomes, quantitative pooling was not undertaken. Findings were synthesized narratively and grouped by mechanistic domains, with interpretation guided by study design to distinguish exploratory mechanistic evidence from clinically validated findings. Diet and nutrition Dietary patterns and eating habits influence male fertility by modulating metabolic homeostasis, hormonal signalling, and oxidative stress [6]. Both insufficient and excessive energy intake can disrupt reproductive physiology, with low body mass index associated with impaired gonadotropin-releasing hormone pulsatility and obesity linked to insulin resistance, altered luteinizing hormone–follicle-stimulating hormone balance, and enhanced steroidogenesis, collectively impairing spermatogenesis [14]. Diets rich in refined carbohydrates and high-glycemic foods may exacerbate hyperglycemia-induced oxidative stress and inflammation, whereas complex carbohydrates and dietary fiber support metabolic stability and insulin sensitivity, indirectly favouring sperm function [15]. Protein source and quality also appear relevant, as plant-based protein intake is generally associated with lower inflammatory burden, while high intake of processed and red meats often co-occurs with dietary patterns linked to metabolic dysfunction, although most evidence remains observational [16–18]. Importantly, associations observed in dietary pattern analyses reflect multifactorial lifestyle and metabolic contexts and should not be interpreted as equivalent to controlled supplementation effects. Dietary fats have been associated with alterations in sperm membrane composition and mitochondrial bioenergetics in experimental and observational settings, with unsaturated fatty acids contributing to membrane fluidity and saturated fat excess associated with oxidative stress and impaired semen parameters [19]. Adequate intake of vitamins and micronutrients supports antioxidant defences, DNA synthesis, and hormonal regulation, yet supplementation benefits vary widely by dose, baseline nutritional status, and population studied [20]. Emerging dietary strategies such as ketogenic or very-low-carbohydrate diets may improve metabolic profiles in obese men however; their reproductive implications remain insufficiently characterized [21]. Antioxidant vitamins and omega-3 fatty acids have been investigated across experimental and observational studies for their roles in redox regulation and membrane composition, though clinical effects remain heterogeneous [3, 5, 22, 23]. In addition, these vitamins support testosterone synthesis and maintain sperm membrane stability, both of which are essential for optimal spermatogenesis and sperm quality [3]. According to observational studies, by increasing membrane fluidity, omega-3 fatty acids, which are frequently present in fish, improve sperm motility and are linked to improved sperm shape [22]. Shared pathophysiological pathways linking diet and male reproductive function Across macronutrients and micronutrients, three interrelated biological pathways consistently emerge in the literature: oxidative stress imbalance, mitochondrial dysfunction, and dysregulated inflammatory signalling [20]. Excess reactive oxygen species impair sperm membrane integrity, disrupt mitochondrial adenosine triphosphate production, and increase DNA fragmentation, whereas inadequate antioxidant capacity compromises redox homeostasis. Inflammatory activation within metabolic tissues and the testicular microenvironment may alter steroidogenesis and spermatogenic efficiency [24]. Importantly, these pathways are supported primarily by mechanistic and animal models, with variable confirmation in human observational cohorts and limited large-scale randomized clinical trials. The following sections discuss how specific nutrients interact with these shared biological processes, with interpretation weighted according to study design and methodological rigor. Carbohydrates and male infertility Dietary composition, particularly carbohydrate quality, has gained increasing attention as a modifiable factor influencing male reproductive health [25]. High glycemic diets rich in simple sugars have been associated with increased oxidative stress markers and adverse sperm parameters in experimental and observational studies [6], while low glycemic, fiber-rich diets like the Mediterranean-style dietary patterns have been associated with improved antioxidant profiles and semen parameters in observational cohorts [26]. Animal models fed high–glycemic or refined carbohydrate diets demonstrate impaired spermatogenesis, increased oxidative damage, and altered steroidogenic gene expression [18, 27–29]. In contrast, dietary regimens incorporating resistant starch, whole grains, legumes, or β-glucan supplementation significantly improve sperm quality, enhance testicular antioxidant capacity, and preserve normal spermatogenic architecture, highlighting the importance of carbohydrate digestibility and structural complexity in maintaining reproductive function [30, 31]. Clinical and epidemiological studies in subfertile and infertile men provide converging evidence. Frequent consumption of sugar-sweetened beverages and refined carbohydrate sources is associated with reduced sperm concentration and motility, increased sperm DNA fragmentation, and poorer semen quality, often mediated by insulin resistance, adiposity, and metabolic dysregulation [32]. In contrast, low–glycemic, fiber-rich carbohydrate patterns are associated with improved metabolic profiles, preserved mitochondrial function, and favorable semen parameters across experimental and observational settings [31, 33]. In vitro studies using human ejaculated spermatozoa and testicular cell systems, including spermatogonial and Sertoli cell models, demonstrate that stable glucose availability and fiber-associated metabolic conditions preserve mitochondrial respiration, sustain ATP production, and maintain sperm motility, while suppressing glucose overload–induced metabolic stress responses that compromise germ cell function [30]. Limited randomized and controlled dietary interventions in infertile men suggest improvements in selected semen parameters, though sample sizes remain modest and outcome reporting is heterogeneous [33]. Diets enriched in whole grains, legumes, and other fiber-rich foods are associated with significant increases in sperm concentration, progressive motility, and normal morphology, alongside reductions in sperm DNA fragmentation, independent of pharmacological or assisted reproductive interventions [33, 34]. Glycemic control represents a plausible mechanistic link connecting carbohydrate composition to redox balance and sperm genomic stability, although definitive clinical causality remains unproven [32, 35]. Impact of proteins on male reproductive health Compared to carbohydrate- associated metabolic effects, which act mainly via metabolic dysregulation, protein sources appear to modulate male reproductive outcomes largely through inflammatory tone and hormonal balance, with most of the available evidence linking dietary protein intake to male fertility coming from observational studies in human populations rather than controlled experimental or randomized clinical trials [2, 35, 36]. These studies typically evaluate overall dietary patterns or habitual food intake, making it difficult to isolate the independent effects of protein source from accompanying nutrients such as saturated fats, fiber, and micronutrients [37]. As a result, current conclusions are largely based on associations between protein-rich dietary patterns and semen parameters, rather than direct mechanistic or causal evidence derived from in vitro or animal models. Several observational studies report that diets higher in plant-based protein sources, including legumes, nuts, seeds, and whole grains, are associated with lower levels of inflammation and oxidative stress, alongside better sperm motility and morphology [2, 22]. In contrast, higher consumption of animal-based proteins, particularly red and processed meats, has been linked to insulin resistance, increased oxidative stress, and systemic inflammation, factors that may negatively influence hormonal balance and sperm quality [5]. However, these associations are not uniform across studies and often weaken after adjustment for body mass index, total energy intake, and lifestyle factors. However, these associations are inconsistent and frequently attenuate after adjustment for body mass index, total energy intake, and lifestyle factors, reflecting substantial heterogeneity in study design and dietary assessment methods [2, 38]. At the molecular level, associations between dietary protein intake and male infertility are supported mainly by human observational studies, rodent models of diet-induced metabolic stress, and targeted metabolic analyses, rather than by randomized controlled trials [39]. Cross-sectional studies in reproductive-age men from fertility clinics and population cohorts consuming animal protein–rich diets, often accompanied by higher saturated fat intake, report associations with reduced sperm concentration and motility and altered seminal metabolic profiles [2, 24]. Experimental animal models and metabolic analyses suggest that high-protein or Western-style dietary patterns may disrupt nutrient-sensing and mitochondrial regulatory pathways within the testis, potentially impairing spermatogenic support under conditions of metabolic excess [40–43]. However, these findings derive primarily from rodent models and associative human metabolic profiling rather than randomized clinical trials. In contrast, plant-based protein patterns, typically studied in observational human cohorts, are associated with more favourable metabolic and inflammatory profiles, yet direct molecular evidence from human testicular tissue or defined germ cell models remains limited [35]. Overall, available data suggest that dietary protein patterns may influence male reproductive physiology through metabolic and mitochondrial pathways; however, causal relationships remain uncertain due to limited interventional evidence. Vitamins and their molecular aspects on male fertility While oxidative stress is a common endpoint across macronutrient imbalances, antioxidant vitamins act primarily by reinforcing endogenous redox defence systems and DNA protection pathways rather than altering energy metabolism or membrane architecture [44, 45]. While oxidative stress represents a common downstream pathway in male infertility, antioxidant vitamins primarily support endogenous redox regulation and genomic stability rather than directly altering metabolic or membrane architecture. The following are some particular functions of important vitamins and how they affect male fertility molecularly: Vitamin A Evidence for the role of vitamin A in male fertility is derived mainly from mechanistic studies using rodent models and in vitro systems rather than from randomized clinical trials in humans [46]. In vitro studies further show that retinoic acid, the active metabolite of vitamin A, acts through nuclear retinoic acid receptors to regulate spermatogonial differentiation [47]. This signalling regulates genes involved in spermatogonial differentiation and meiotic entry [48]. Across rodent models, vitamin A deficiency results in spermatogenic arrest, disrupted meiosis, and reduced sperm output, effects that are reversible following retinoic acid repletion. In contrast, human evidence remains limited to observational studies, with no standardized supplementation doses or fertility-specific clinical endpoints, limiting causal inference and translational relevance [46]. Vitamin C The antioxidant role of vitamin C in male fertility has been examined mainly in observational human studies and small randomized supplementation trials, with limited mechanistic work. Clinical studies have primarily involved men with infertility, recurrent pregnancy loss, or elevated oxidative stress, rather than healthy normozoospermic populations [49]. In a randomized clinical trial involving male partners of couples with recurrent pregnancy loss, vitamin C supplementation (typically 500–1,000 mg/day) was associated with reduced oxidative DNA damage and altered expression of sperm chromatin–related genes, including PRM1 and PRM2, indicating improved DNA packaging [50]. At the molecular level, vitamin C acts in seminal plasma to scavenge ROS and regenerate oxidized vitamin E, leading to lower levels of oxidative damage markers such as 8-OHdG. Improvements in sperm concentration, motility, and morphology have been reported in some studies; however, results are heterogeneous, and benefits appear largely confined to men with pre-existing oxidative stress rather than the general population [5, 50]. Vitamin D Evidence linking vitamin D to male fertility arises from a combination of cellular studies, animal models, observational cohorts, and a limited number of supplementation trials. Mechanistic studies demonstrate that the vitamin D receptor (VDR) is expressed in human Sertoli cells, Leydig cells, and mature spermatozoa, supporting a direct role in testicular function. In rodent models, vitamin D deficiency alters calcium signalling and steroidogenic pathways, with associated changes in spermatogenic efficiency. Observational studies in human populations, primarily involving infertile or subfertile men, consistently associate low serum 25-hydroxyvitamin D levels with reduced sperm motility, lower sperm counts, and altered testosterone levels. Supplementation trials (commonly 2,000–4,000 IU/day) report modest improvements in some vitamin D–deficient men, while several studies show null effects, underscoring population-specific responses and methodological variability [51, 52]. Vitamin E The reproductive effects of vitamin E have been studied using animal models of testicular oxidative stress, in vitro systems, and clinical studies in men with idiopathic or oxidative stress–related infertility. Rodent models exposed to testicular oxidative stress show that vitamin E supplementation is associated with reduced lipid peroxidation markers such as malondialdehyde (MDA) and preserves sperm membrane integrity. These effects are linked to stabilization of PUFAs within sperm membranes. Human supplementation studies, typically administering 200–400 IU/day, report improvements in sperm motility and morphology, particularly in men with elevated ROS levels. However, responses vary widely, and evidence supporting routine vitamin E supplementation in men without documented oxidative stress remains limited, highlighting uncertainty regarding clinical generalizability [4, 53]. Vitamin B9 (Folate) The association between folate and male fertility is supported by mechanistic studies, animal models, and observational human data, with relatively few controlled intervention trials. Experimental studies in rodents demonstrate that folate deficiency disrupts DNA synthesis and methylation, leading to impaired spermatogenesis and increased germ cell apoptosis [54]. In subfertile or infertile men, low folate intake or serum levels have been associated with abnormal sperm DNA methylation, increased sperm aneuploidy, and reduced sperm concentration [55]. Molecular analyses implicate altered regulation of one-carbon metabolism pathways affecting DNA methylation and chromatin stability [56]. While higher folate intake is generally associated with improved semen parameters, interventional evidence remains inconsistent and appears influenced by genetic polymorphisms and baseline nutritional status [57]. Vitamin B12 Evidence for vitamin B12 in male fertility includes observational studies and small supplementation trials, with limited mechanistic data from experimental systems [58]. Vitamin B12 functions as a cofactor in the methionine cycle, facilitating production of S-adenosylmethionine (SAM), a key methyl donor for DNA methylation. Deficiency has been associated in human observational studies, mainly among infertile men, with reduced sperm count, impaired motility, and altered chromatin compaction. Molecular findings suggest dysregulation of methylation-dependent processes affecting sperm DNA integrity. Supplementation studies (commonly 500–1,500 µg/day) report improvements in semen parameters primarily in B12-deficient individuals; however, outcomes are inconsistent, and evidence from large, well-controlled clinical trials remains insufficient [57, 58]. Across vitamins, reported benefits are largely confined to correction of deficiency states or populations with elevated oxidative stress. Current evidence does not support routine high-dose supplementation in nutritionally adequate men, and clinical translation remains limited by heterogeneity in study design, dosing, and outcome measures. Nutritional modulation of oxidative stress in male fertility Physiological levels of ROS are required for normal sperm functions, including capacitation and the acrosome reaction, as demonstrated primarily in in vitro sperm studies and animal models [59]. However, excessive accumulation of ROS has been consistently associated with impaired sperm function in observational human studies, particularly among men exposed to smoking, obesity, environmental pollutants, infections, and suboptimal dietary patterns [60]. Clinical semen analyses link elevated oxidative stress with lipid peroxidation of the sperm plasma membrane, reduced membrane fluidity, and compromised fertilization potential. Lipid peroxidation also generates secondary aldehydes such as malondialdehyde, which has been repeatedly associated with abnormal sperm morphology and reduced motility in infertile men, although causal relationships in humans remain difficult to establish [61]. The evidence summarized below derives from a combination of in vitro experiments, animal models, observational human studies, and a limited number of supplementation trials; these forms of evidence differ substantially in translational strength. At the molecular level, mechanistic evidence from rodent models and testicular cell systems indicates that oxidative stress disrupts mitochondrial function, leading to impaired adenosine triphosphate production and reduced sperm motility [62]. Increased ROS exposure has also been linked to sperm DNA fragmentation and genomic instability in both animal models and human observational studies, outcomes that are clinically associated with poor fertilization rates, recurrent implantation failure, and pregnancy loss [63]. Endogenous antioxidant defence systems, including SOD, catalase, and GPX, play a central role in limiting oxidative damage. Experimental studies identify several antioxidant and redox-regulatory pathways as important modulators of mitochondrial integrity and germ cell survival [64]. Among these pathways, transcriptional regulators of antioxidant defence have been implicated in maintaining sperm viability and limiting lipid peroxidation in experimental models. However, most gene-level evidence derives from murine systems, and human data remain largely associative rather than interventional [61, 65, 66]. Within the oxidative stress framework, several dietary antioxidants have been investigated using defined experimental systems and human clinical cohorts. Coenzyme Q10 has been evaluated primarily in in vitro studies using ejaculated human spermatozoa obtained from normozoospermic and infertile men, as well as in randomized and non-randomized clinical trials involving men with idiopathic infertility and varicocele [67]. In vitro studies suggest that CoQ10 supports electron transport chain activity and mitochondrial membrane stability, although direct gene-level validation in mature human sperm is limited. Clinical supplementation studies report improvements in sperm motility and reductions in oxidative stress markers in some infertile populations, although heterogeneity in study design and outcome measures limits firm conclusions [67, 68]. Lycopene has been examined predominantly in observational human cohorts and small interventional trials involving men with idiopathic infertility, as well as in experimental oxidative stress models using rat testes and cultured Leydig and Sertoli cells. Animal studies under pro-oxidant conditions suggest that lycopene may modulate antioxidant-response and apoptosis-related pathways, thereby preserving germ cell integrity. In humans, lycopene intake has been associated with improvements in sperm concentration and morphology in small studies, although mechanistic insights in humans remain limited [69]. Overall, while both antioxidants demonstrate beneficial associations with sperm quality and oxidative stress mitigation, the molecular evidence remains uneven, with robust mechanistic data derived mainly from animal and cell-based models and limited gene-level validation in human reproductive cells [70]. Polyphenols such as resveratrol have been investigated mainly in animal models and in vitro sperm and Sertoli cell systems. Experimental studies report reduced ROS generation and modulation of oxidative stress–related pathways, improved mitochondrial membrane potential, and modulation of oxidative stress related pathways, including SIRT1 activation. However, human clinical data remain limited, and fertility-specific dose thresholds have not been established [71]. These studies do not include molecular endpoints, limiting mechanistic interpretation [72, 73]. Amino acids contribute to redox regulation and mitochondrial metabolism through complementary mechanisms. L-arginine has been examined in animal models and small human interventional trials, most commonly involving 20 to 40 men with oligoasthenozoospermia, using supplementation doses of 2 to 4 g per day. In these cohorts, modest improvements in sperm concentration and motility have been reported. Mechanistic evidence from animal models suggests nitric oxide–mediated effects on testicular blood flow and mitochondrial function; however, human molecular validation remains limited [74–76]. L-carnitine has been evaluated in rat models and controlled human studies, typically enrolling 30 to 60 infertile men, at doses ranging from 1 to 3 g per day, with reported improvements in sperm motility in some infertile cohorts, while molecular evidence for enhanced mitochondrial beta-oxidation derives largely from experimental systems rather than direct human analyses [77]. Taurine has been studied mainly in animal models and in vitro sperm systems, with human data limited to observational cohorts of infertile men rather than randomized trials, where associations with improved antioxidant status and sperm motility have been described in observational settings, but causal effects remain uncertain [51]. Overall, although oxidative stress represents a biologically plausible and clinically relevant pathway in male infertility, much of the molecular evidence supporting specific nutritional interventions derives from animal models and in vitro systems. Human supplementation studies are generally small, heterogeneous, and often limited to men with established infertility or elevated oxidative stress. Current evidence therefore supports correction of deficiency or oxidative imbalance rather than routine antioxidant supplementation in the general population. Mitochondrial function and sperm health Mitochondrial activity is essential for sperm motility through adenosine triphosphate generation by oxidative phosphorylation, a process characterized mainly in human spermatozoa and supported by animal studies [62]. Molecular analyses in experimental models suggest that mitochondrial efficiency in sperm is regulated by pathways involved in electron transport and mitochondrial maintenance. Nitric oxide derived from L-arginine has been shown in animal and in vitro sperm studies to modulate mitochondrial respiration by limiting electron leakage from the respiratory chain, thereby reducing excessive ROS formation without suppressing physiological signalling [62, 75]. Dysregulation of nitric oxide signalling has been associated in experimental systems with mitochondrial DNA damage and altered mitochondrial biogenesis, contributing to impaired sperm motility [78]. L-carnitine has been evaluated in rodent models and in human supplementation studies, commonly at doses between 1 and 3 g per day, with reported improvements in sperm motility and mitochondrial function [77]. These effects are linked to enhanced beta oxidation of long-chain fatty acids and improved mitochondrial energy metabolism required for sustained adenosine triphosphate production. Taurine has been studied primarily in animal models and in vitro sperm systems, where it is reported to preserve mitochondrial membrane potential and calcium homeostasis, although human interventional data remain limited [51]. Beyond mitochondrial metabolism, L-arginine serves as a precursor for polyamines such as putrescine, spermidine, and spermine, which are critical for spermatogenesis. Animal studies demonstrate that altered polyamine metabolism influences chromatin packaging and germ cell proliferation. Disruption of these pathways has been associated with compromised sperm DNA integrity and reduced fertilization potential in experimental systems. Disruption of these pathways leads to compromised sperm DNA integrity and reduced fertilization potential. Human evidence linking polyamine-related gene regulation to infertility remains largely observational, but experimental models support a mechanistic role for polyamines in maintaining sperm chromatin stability, although direct clinical validation in humans remains limited [76]. Overall, while mitochondrial dysfunction represents a biologically plausible contributor to male infertility, much of the mechanistic evidence linking specific nutrients to mitochondrial regulation derives from animal and in vitro studies. Human supplementation trials are generally small and heterogeneous, and current evidence does not support routine clinical use beyond correction of identified deficiencies or documented metabolic impairment. Fatty acid classifications and their roles in male reproduction Fatty acids are essential components of male reproductive physiology, contributing to sperm membrane structure, mitochondrial energy metabolism, and cellular signalling. Evidence for their roles comes from a mix of observational human studies, controlled supplementation trials, and mechanistic investigations in animal models and isolated sperm cells [35]. Based on saturation, fatty acids are broadly classified as saturated fatty acids, monounsaturated fatty acids, and PUFAs, each with distinct effects on sperm quality and function. The strength of evidence varies considerably across fatty acid classes, with mechanistic data often preceding large-scale randomized clinical validation. High intake of saturated fatty acids has been examined mainly in human observational studies where habitual dietary data are linked to semen parameters. In these observational studies, high dietary saturated fat intake has been associated with lower sperm concentration and reduced motility, potentially through altered lipid composition and increased susceptibility of sperm membranes to oxidative damage [79]. Mechanistic work in rodent models and cell systems suggests that excess saturated fats may disrupt lipid handling and antioxidant pathways, potentially compromising membrane stability and mitochondrial function; however, direct molecular confirmation in human sperm is limited. Monounsaturated fatty acids, particularly oleic acid, are associated with better semen quality in observational human cohorts and dietary pattern analyses that include Mediterranean or prudent diets. In these observational studies, higher monounsaturated fat intake has been correlated with improved motility and morphology [79, 80]. Functionally, monounsaturated fatty acids enhance membrane fluidity, which is required for capacitation, acrosome reaction, and sperm–oocyte fusion. Experimental studies suggest that monounsaturated fats may support mitochondrial ATP production through beta oxidation, although direct transcriptomic analyses in human sperm are scarce. PUFAs, especially omega-3 and omega-6 fatty acids, are most extensively studied in the context of male fertility. Docosahexaenoic acid, an omega-3 fatty acid, is highly incorporated into sperm phospholipid bilayers and is essential for membrane flexibility and mitochondrial performance [80, 81]. In mechanistic studies, omega-3 fatty acids influence pathways involved in mitochondrial dynamics and lipid metabolism, although most gene-level evidence derives from animal models. In human supplementation trials involving men with idiopathic infertility, doses of combined docosahexaenoic acid and eicosapentaenoic acid ranging from 1 to 2 g per day over several months have been associated with modest improvements in sperm concentration, motility, and seminal antioxidant capacity, although outcomes vary considerably across studies [82, 83]. Systematic reviews underscore that these benefits are not uniform and may depend on baseline dietary patterns and metabolic status. Importantly, correction of documented omega-3 insufficiency may restore membrane composition and redox balance, whereas high-dose supplementation beyond physiological requirements may increase lipid peroxidation due to the high oxidative susceptibility of polyunsaturated fatty acids. Omega-6 fatty acids, such as arachidonic acid, are required for normal sperm physiology because they serve as precursors for prostaglandin synthesis, which modulates sperm motility and acrosome reaction. However, observational data and experimental work indicate that an imbalance favoring excess omega-6 relative to omega-3 has been associated with increased pro-inflammatory signalling and lipid peroxidation in observational and experimental settings, contributing to sperm DNA fragmentation and reduced viability. This is reflected in alterations in cyclooxygenase and lipoxygenase pathway activity rather than direct modulation of spermatogenesis-specific genes [82, 83]. Taken together, these studies suggest that dietary fatty acid composition may influence male reproductive physiology. However, much of the mechanistic insight derives from animal and cell-based systems, and human intervention trials remain heterogeneous in design, dose, and population characteristics. Current evidence therefore supports maintaining balanced dietary fatty acid intake rather than advocating high-dose supplementation in the absence of deficiency or documented imbalance. In clinical contexts, both inadequate intake and excessive supplementation may perturb redox homeostasis and inflammatory signalling, underscoring the need for individualized assessment rather than universal dosing strategies. Discussion The relationship between nutrition and male fertility has been increasingly examined in recent years, reflecting recognition of dietary factors as potentially modifiable components within a multifactorial condition. However, the current body of literature remains heterogeneous, with findings often inconsistent across study designs, populations, and nutrient categories. Much of the existing evidence remains observational or mechanistic, with established causality seldom demonstrated in adequately powered randomized clinical trials. Notably, correction of established nutritional deficiencies may have distinct biological effects, like, disrupting physiological ROS signalling required for capacitation and acrosome reaction, while supra-physiological or high-dose supplementation, as excessive nutrient exposure, has the potential to disrupt physiological redox balance and endocrine regulation rather than provide incremental benefit. This distinction highlights the importance of considering baseline nutritional status and dosing context when interpreting reported associations. Across dietary domains, male infertility may reflect the convergence of diverse nutritional inputs onto shared cellular vulnerabilities, including redox imbalance, mitochondrial dysfunction, impaired membrane integrity, and altered endocrine signalling. Carbohydrates are hypothesized to influence fertility through metabolic pathways, where insulin resistance, altered glucose handling, and disrupted hypothalamic–pituitary–gonadal signalling may indirectly impair spermatogenesis. However, human evidence remains largely observational, with several studies reporting null or inconsistent associations between carbohydrate quality and semen parameters after adjustment for body mass index, physical activity, and total energy intake. These findings highlight the difficulty of isolating macronutrient-specific effects from broader dietary patterns and metabolic status. Protein intake shows similarly heterogeneous associations. Diets higher in animal-derived protein have been correlated in observational studies with increased markers of systemic inflammation and oxidative stress, while plant-based protein patterns tend to associate with more favourable semen parameters. Nevertheless, these associations weaken substantially when confounders such as saturated fat intake, obesity, smoking, and alcohol consumption are considered. Mechanistic interpretations suggest that protein-related effects may operate indirectly through inflammatory and metabolic signalling rather than through direct regulation of spermatogenesis-specific pathways, and negative or null findings are common across cohort studies. This inconsistency underscores the challenge of attributing reproductive effects to protein source alone within mixed dietary exposures. Fatty acids represent a biologically plausible dietary factor due to their structural role in sperm membranes and contribution to mitochondrial bioenergetics. Omega-3 PUFAs, particularly DHA, have been associated in experimental models with improved membrane fluidity, motility, and mitochondrial efficiency in experimental models. However, human trials report variable outcomes, with several randomized studies failing to demonstrate consistent improvements in semen quality or fertility endpoints. Differences in baseline nutritional status, supplementation dose, study duration, and semen analysis protocols likely contribute to these discrepancies. Importantly, these inconsistencies caution against broad claims regarding fatty acid supplementation in the absence of individualized or context-specific evidence. Antioxidants and micronutrients have been extensively studied due to the sensitivity of spermatozoa to oxidative damage. Vitamins C and E, selenium, zinc, and carotenoids are frequently associated with improved redox balance and reduced sperm DNA damage, yet clinical findings remain mixed. Several trials report modest benefits, while others show no effect or suggest potential harm with excessive supplementation. Emerging evidence from human studies indicates that supraphysiological antioxidant intake may induce reductive stress, disrupting physiological ROS signalling required for capacitation and acrosome reaction. This is particularly relevant in men with metabolic disorders or inflammatory comorbidities, where redox balance is already altered. Taken together, these observations highlight the importance of differentiating between correction of documented deficiencies and indiscriminate high-dose supplementation. Importantly, most reported benefits occur in men with documented oxidative stress or subfertility, and current evidence does not support routine high-dose antioxidant use in otherwise healthy, nutritionally adequate individuals. Amino acids such as L-arginine, L-carnitine, and taurine contribute to mitochondrial metabolism, nitric oxide signalling, and chromatin stability, with supportive evidence from animal and small human studies. However, population sizes are often limited, mechanistic biomarkers are rarely assessed in human sperm, and dose–response relationships remain poorly defined. As with other nutrients discussed in this review, most molecular insights derive from animal and in vitro systems, and translation into standardized clinical practice remains premature. Methodological limitations substantially constrain interpretation across all nutrient categories. Observational studies dominate the field and are particularly vulnerable to recall bias, dietary misclassification, and residual confounding from lifestyle and environmental factors such as smoking, alcohol use, endocrine-disrupting chemicals, stress, and occupational exposures. Dietary intake is often assessed using food frequency questionnaires, which lack precision for micronutrient quantification and fail to capture long-term dietary variability. In addition, semen analysis protocols vary widely between studies, further contributing to inconsistent outcomes. As a scoping review, the present work aimed to map the breadth of available evidence rather than formally appraise study quality or conduct meta-analysis, which should be considered when interpreting the conclusions. Population heterogeneity represents another critical challenge. Many studies are conducted in Western populations characterized by a higher prevalence of obesity, sedentary behaviour, and ultra-processed food consumption, which may amplify metabolic and inflammatory pathways relevant to infertility. These factors differ markedly from dietary and lifestyle contexts in non-Western populations, limiting the generalizability of findings and complicating cross-study comparisons. These contextual differences underscore the importance of interpreting nutritional associations within specific metabolic, cultural, and environmental settings rather than extrapolating findings universally. Limitations Several limitations of the current evidence base must be acknowledged. Most studies are observational or short-term interventions with small sample sizes, limiting causal inference and statistical power. Randomized controlled trials with fertility-relevant endpoints remain scarce, and many rely on surrogate markers such as sperm concentration or motility rather than pregnancy or live birth outcomes. There is also a lack of standardized nutrient dosing, intervention duration, and biomarker assessment across studies. Confounding by body mass index, metabolic health, smoking, alcohol intake, psychological stress, and environmental exposures is inconsistently addressed, and few studies incorporate genetic or epigenetic stratification. Additionally, isolating nutrient-specific effects is challenging within complex dietary patterns, and interactions between nutrients are rarely examined. These limitations collectively highlight the need for longitudinal cohorts, well-powered randomized trials, and validated mechanistic biomarkers to advance the field. As a scoping review, this study aimed to map the breadth and mechanistic scope of available literature rather than perform a formal quality appraisal or meta-analysis. Although the Methods section emphasized human studies, mechanistic data from animal and in vitro systems were included where necessary to contextualize biological plausibility. This approach may create apparent inconsistency in evidentiary weighting, and findings should therefore be interpreted as exploratory rather than confirmatory. Conclusion This review synthesizes current evidence examining the relationship between nutrition and male reproductive health, highlighting multiple biologically plausible molecular pathways through which diet may influence fertility-related processes (Table 1). However, much of the available evidence remains observational or mechanistic, and clinically validated effects are limited (Figs. 1 and 2). Current evidence suggests that diet may influence male fertility through metabolic, inflammatory, and redox-related pathways, although the majority of supporting data derive from associative human studies and experimental models rather than large randomized clinical trials. Importantly, mechanistic findings from animal and in vitro systems should be interpreted as biologically informative but not clinically confirmatory, and their translational relevance to routine infertility care remains to be established. Rather than supporting generalized dietary prescriptions, existing data underscore the importance of context-specific interpretation, careful consideration of baseline nutritional status, and avoidance of excessive supplementation. Table 1Nutritional factors and reported molecular associations relevant to male reproductive functionNutrientReported molecular associations(selected genes/pathways)ReferencesVitamin CAntioxidant defence pathways (NRF2); associated with reduced oxidative stress markers and sperm DNA integrity parameters [5]Vitamin DVDR-mediated signalling linked to calcium regulation and testosterone-related pathways implicated in motility [10]Vitamin EGPX4-related antioxidant activity associated with reduced lipid peroxidation markers [21]Vitamin ASTRA8 activation in pathways involved in spermatogonial differentiation (primarily experimental models) [41]Folate (B9)STRA8 activation in pathways involved in spermatogonial differentiation (primarily experimental models) [84]ZincMetallothionein activity and androgen-related pathways associated with membrane stability [3]SeleniumGPX4-associated antioxidant enzyme pathways implicated in oxidative stress regulation [3]Omega-3 PUFAsFADS1/FADS2-mediated lipid metabolism linked to membrane fluidity and mitochondrial function markers [25]L-ArginineNOS3-related nitric oxide pathways implicated in spermatogenesis and motility (experimental data) [31]L-CarnitineCPT1A-dependent fatty acid transport and mitochondrial energy metabolism pathways [32]TaurineCATSPER1-associated calcium signaling pathways relevant to motility regulation (primarily preclinical) [7]LycopeneSOD1-related antioxidant pathways associated with oxidative stress modulation [20]Coenzyme Q10PGC-1α-linked mitochondrial bioenergetic regulation pathways [30]GlucoseGLUT-mediated glycolytic pathways contributing to sperm energy metabolism [43]FructoseALDOB-associated metabolic pathways providing seminal energy substrate [44] Nutritional factors and reported molecular associations relevant to male reproductive function Integrated conceptual framework of nutritional modulation of male fertility. The diagram illustrates how nutritional factors influence multiple interconnected biological domains that collectively determine the Male Fertility Index. Nutrients regulate spermatogenesis through epigenetic mechanisms and ROS signalling pathways, while also modulating endocrine function via the GnRH–LH/FSH–testosterone axis and androgen receptor activity. Sperm motility is supported through mitochondrial bioenergetics, cAMP/PKA signalling, fatty acid β-oxidation, and Ca²⁺ regulation, whereas sperm morphology is influenced by structural integrity and membrane lipid remodelling. Oxidative balance underpins all domains through coordinated regulation of ROS production and antioxidant defence systems, including Nrf2 and glutathione pathways. The bidirectional arrows indicate feedback interactions and synergistic crosstalk among pathways, emphasizing that changes in one domain may influence others. GnRH, gonadotropin-releasing hormone; LH, luteinizing hormone; FSH, follicle-stimulating hormone; cAMP, cyclic adenosine monophosphate; PKA, protein kinase A; Ca²⁺, calcium; ROS, reactive oxygen species; Nrf2, nuclear factor erythroid 2–related factor 2 At present, evidence supports maintenance of overall dietary adequacy and correction of documented deficiencies rather than routine high-dose supplementation or targeted nutritional interventions in unselected populations. Supra-physiological dosing of antioxidants and micronutrients may disrupt physiological redox balance and endocrine regulation, with emerging evidence suggesting potential reductive stress or null effects in randomized trials. Therefore, high-dose supplementation should not be assumed to confer benefit and requires careful evaluation within appropriately designed clinical studies. Future research should prioritize rigorously designed, adequately powered randomized trials with fertility-relevant clinical endpoints, standardized nutrient dosing, and integration of validated molecular biomarkers to clarify whether observed mechanistic associations translate into meaningful reproductive outcomes. In routine clinical practice, nutritional management in male infertility should therefore prioritize assessment of overall dietary quality and identification of correctable deficiencies, integrated within comprehensive medical evaluation rather than implemented as a stand-alone therapeutic strategy. Acknowledgements The respective authors would like to give hearty thanks to management of Symbiosis International (Deemed University) for providing facilities to carry the work successfully. Abbreviations 8-Hydroxy-2′-Deoxyguanosine Acyl-CoA Dehydrogenase Medium Chain Adenosine Triphosphate ATP Synthase F1 Subunit Alpha Branched-Chain Keto Acid Dehydrogenase E1 Subunit Alpha Branched-Chain Amino Acid Transaminase B-Cell Lymphoma 2 Catalase Coenzyme Q10 Carnitine Palmitoyltransferase 1 A Cytochrome P450 Family 11 Subfamily A Member 1 Docosahexaenoic Acid Deoxyribonucleic Acid DNA Methyltransferases Eicosapentaenoic Acid Fatty Acids Follicle-Stimulating Hormone Germ Cell-1 Glutathione Peroxidase Glutathione Peroxidase 4 Heme Oxygenase 1 3-Beta-Hydroxysteroid Dehydrogenase Interleukin-6 KIT Proto-Oncogene Receptor Tyrosine Kinase Luteinizing Hormone Malondialdehyde Mitochondrially Encoded Cytochrome C Oxidase 1 Mitochondrially Encoded NADH Dehydrogenase 1 Mechanistic Target of Rapamycin Monounsaturated Fatty Acids NADH: Ubiquinone Oxidoreductase Core Subunit S1 Nitric Oxide NADPH Oxidases 2 and 5 NAD(P)H Quinone Dehydrogenase 1 Nuclear Factor Erythroid 2–Related Factor 2 Peroxisome Proliferator–Activated Receptor Gamma Coactivator 1 Alpha DNA Polymerase Gamma Peroxisome Proliferator-Activated Receptor Alpha Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1 Alpha Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews Protamine Protamine 1 Protamine 2 Polyunsaturated Fatty Acids Retinoic Acid Receptor Alpha Retinoic Acid Receptor Beta Retinoic Acid Receptor Gamma Randomized Controlled Trials Reactive Oxygen Species Ribosomal Protein S6 Kinase Beta-1 S-Adenosylmethionine Sirtuin 1 Superoxide Dismutase Superoxide Dismutase 1 Steroidogenic Acute Regulatory Protein Stimulated by Retinoic Acid Gene 8 Synaptonemal Complex Protein 3 Mitochondrial Transcription Factor A Tumor Necrosis Factor Alpha Transition Protein 1 Uncoupling Protein 2 Vitamin D Receptor Author contributions SRN designed the concept and SRN, YAA drafted the manuscript. SRN and MS participated in the editing of the manuscript. SRN gave the final approval for the final version to be submitted for publication. Funding Open access funding provided by Symbiosis International (Deemed University). Not applicable. Data availability Not applicable. Declarations Ethics approval and consent to participate Not applicable. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement Not applicable.